BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Healthtrust Education - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://education.healthtrustpg.com
X-WR-CALDESC:Events for Healthtrust Education
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20180313T113000
DTEND;TZID=UTC:20180313T123000
DTSTAMP:20260409T085914
CREATED:20180205T211225Z
LAST-MODIFIED:20180322T221441Z
UID:10001191-1520940600-1520944200@education.healthtrustpg.com
SUMMARY:"Identification & Treatment of Sepsis in the Pediatric Population"
DESCRIPTION:HealthTrust presents…“Identification & Treatment of Sepsis in the Pediatric Population“ \nDownload a copy of this presentation \nAccess the recording. \nIdentifying true cases of sepsis in children can be challenging\, considering septic shock in adults usually presents as warm shock versus cold shock as is typically the case in pediatric patients. As a result\, recognition of pediatric sepsis can be delayed\, causing further complications. This session will review the definition of sepsis as well as SIRS\, severe sepsis and septic shock. The presenter will provide detailed information on pathophysiology\, causes and treatment guidelines\, and the use of trigger tools in treating pediatric sepsis. Because the use of steroids in pediatric sepsis is as controversial as refractory therapy\, the presenter will discuss the importance of pharmacists being aware of a treatment algorithm when first and second line therapies fail. \nLearning Objectives for PharmD member attendees: \nAt the end of this session\, participants should be able to: \n\nDefine the different types of sepsis\nDescribe the pathophysiology of sepsis\nDiscuss etiology and current treatment guidelines for pediatric sepsis\nAssess limitations of current guidelines\nEvaluate the benefits of early goal-directed therapy\nAssess the use of steroids in pediatric sepsis\n\nLearning Objectives for Pharmacy Technician member attendees: \nAt the end of this session\, participants should be able to: \n\nList the commonly used vasoactive agents in pediatric sepsis\nDiscuss preparation instructions for such agents\nState monitoring parameters for various agents\nIdentify potential adverse effects for each agent\n\n Presenter: \n \nPriya Narang\, PharmD\, MS  |  PGY-1 pharmacy practice resident at Atlantic Health System \nTarget Audience:  PharmD and Pharmacy Technicians \nContinuing Education Information: 1.0 contact hours for Pharmacists and Pharmacy Technicians. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-0000-18-030-L04-P and 0863-0000-18-030-L04-T . The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists and technicians who attend the webinar and complete the online evaluation. \nNote:  No group credit is available. HealthTrust’s CE credit provider requires that each participant register and join the actual webinar event individually.
URL:https://education.healthtrustpg.com/calendar/identification-treatment-sepsis-pediatric-population/
CATEGORIES:Pharmacy
END:VEVENT
END:VCALENDAR